醫療保健領域的數位化轉型和新興技術 - 2022 年版

本報告調查和分析了醫療保健行業的數位化轉型和先進技術，提供了有關 COVID-19 和通貨膨脹的影響、數位化轉型的關鍵因素和挑戰以及先進技術的投資趨勢的信息。

內容

第一章目的□□與設計

第 2 章數位化轉型概述

• 數位化轉型概述
• COVID-19 對數位化轉型的影響

第 3 章數位化轉型戰略

• 數位化轉型戰略
• COVID-19 危機期間臨床試驗中斷
• 處理臨床試驗中的困惑
• COVID-19 之後醫生與製藥公司銷售代表之間的互動
• COVID-19 對社交媒體使用的影響

第 4 章數位化轉型的目的

• 數位化轉型的目的 - COVID-19
• 與製藥行業的技術合作夥伴關係
• 數位化轉型的目的
• 數位化轉型的增長

第 5 章：數位化轉型的障礙

第 6 章對數位化轉型的關注

• 與數位化轉型相關的問題
• 對數位化轉型的擔憂 - 用他們的話說

第 7 章數位化轉型的必要性

第 8 章先進技術 - 投資趨勢

• 先進技術
• COVID-19 對先進技術投資的影響
• 製造業機器人技術的未來
• 顛覆性的先進技術
• AI 和大數據的工作分析圖
• 顛覆性的先進技術 - 用他們自己的話來說
• 案例研究 - 人工智能在藥物發現過程中的作用
• 案例研究 - COVID-19 期間遠程醫療的擴展
• 案例研究 - 使用 AI 進行藥物再利用和篩選
• 案例研究 - AI 和個性化醫療的未來
• 案例研究 - AI 在對抗 COVID-19 的鬥爭中獲勝

第 9 章主要發現摘要

第 10 章附錄

第 11 章聯繫人

The pharmaceutical industry is undergoing constant changes resulting from declining profit margins, cost pressure, necessity to replenish pipelines and maximize peak sales, while at the same time meeting stringent regulatory and legislative requirements. Although adoption of innovative technologies was seen as one of the ways to ease these pressures, the COVID-19 pandemic made digitalization of the sector even more pressing. Nevertheless, increasing inflation, fueled by the COVID-19 pandemic and geopolitical events such as the ongoing Ukraine conflict started to challenge digital transformation efforts in the healthcare sector.

Scope

In this report, GlobalData tracks the progress of digital transformation in the healthcare industry, examines the business preparedness to embrace innovations, and uncovers the current and future technology-related investment trends.

Objectives

• Benchmark the level of business readiness and adoption
• Better understand the business functions impacted the most
• Assess barriers to adoption
• Define requirements for success
• Determine the importance of emerging technologies to healthcare organizations
• Evaluate levels of investment
• Assess the impact of COVID-19 on digitalization efforts
• Explore how inflation is affecting digital transformation progress

Study Design

A total of 114 GlobalData Pharma clients and prospects participated in the 10-minute survey, which was fielded from September 14, 2022, to October 10, 2022.

Components of the report include -

• Scope of Digital Transformation Strategies - main objectives of digital strategy within the pharmaceutical industry providing respondent mix by region, company size, and respondent seniority.
• COVID-19 Pandemic and Digital Transformation - assesses the impact of COVID-19 on the speed of digital transformation and innovation in pharmaceutical industry.
• Inflation Impact on Digital Transformation - examines how the inflation is impacting digital transformation efforts.
• Challenges to Digital Transformation - highlights key hinderances healthcare organizations face when implementing digital transformation providing respondent mix by region and company size.
• Important Factors for Digital Transformation - determines the key factors required to successfully implement digital transformation providing respondent mix by company size.
• Uptake of Emerging Technologies - examines the key emerging technologies being invested in by healthcare organizations providing respondent mix by region and company size.
• Impact of emerging technologies on pharmaceutical sector - provides the analysis and insights on how technologies are being applied in the healthcare industry and what improvements in business processes these technologies can provide.

Reasons to Buy

• Stay up to date on the scope, challenges, and essentials for the digital transformation within the healthcare industry.
• Explore how innovations are transforming the healthcare industry and what impact on the sector these technologies will have in the near future.
• Develop and design your corporate strategies through an in-house expert analysis of the key factors of digital transformation and emerging technology in the healthcare sector.
• Develop business strategies by understanding the key factors of digital transformation and emerging technology in the healthcare sector.
• Identify emerging industry trends in the uptake of emerging technologies to gain a competitive advantage.

Table of Contents

Table of Contents

1. Objectives and Design

• 1.1.1. Respondent Mix
• 1.1.2. Key Findings

2. Overview of Digital Transformation

• 2.1.1. Overview of Digital Transformation
• 2.1.2. COVID-19 Impact of Digital Transformation

3. Digital Transformation Strategies

• 3.1.1. Digital Transformation Strategies
• 3.1.2. Clinical Trial Disruptions during COVID-19 Crisis
• 3.1.3. Addressing Clinical Trial Disruptions
• 3.1.4. Physician Interactions with Pharma Sales Reps Post-COVID-19
• 3.1.5. Impact of COVID-19 on Social Media Usage

4. Digital Transformation Objectives

• 4.1.1. Digital Transformation Objectives - COVID-19
• 4.1.2. Collaboration Between Pharmaceutical Industry and Tech
• 4.1.3. Digital Transformation Objectives
• 4.1.4. Digital Transformation Growth

5. Obstacles to Digital Transformation

6. Concerns Associated with Digital Transformation

• 6.1.1. Concerns Associated with Digital Transformation
• 6.1.2. Concerns Associated with Digital Transformation - In Their Words

7. Necessities for Digital Transformation

8. Emerging Technologies - Investment Trends

• 8.1.1. Emerging Technologies
• 8.1.2. COVID-19 Impact on Investment in Emerging Technologies
• 8.1.3. The Future of Robotics in Manufacturing
• 8.1.4. Disruptive Emerging Technologies
• 8.1.5. Job Analytic Graphs on AI and Big Data
• 8.1.6. Disruptive Emerging Technologies - In Their Words
• 8.1.7. Case Study - AI's Role in Drug Discovery Process
• 8.1.8. Case Study - Telehealth Expansion During COVID-19
• 8.1.9. Case Study - Drug Repurposing and Screening Using AI
• 8.1.10. Case Study - AI and the Future of Personalized Medicine
• 8.1.11. Case Study - AI Triumphs in the Fight Against COVID-19

9. Summary of Key Findings

• 9.1.1. Digital Transformation - In Their Words
• 9.1.2. Key Findings

10. Appendix

• 10.1.1. Bibliography
• 10.1.2. About the Authors

11. Contact Us